Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2017, Article ID 6468097, 9 pages
https://doi.org/10.1155/2017/6468097
Research Article

Sustained High Levels of Both Total and High Molecular Weight Adiponectin in Plasma during the Convalescent Phase of Haemorrhagic Fever with Renal Syndrome Are Associated with Disease Severity

Department of Immunology, The Fourth Military Medical University, Xi’an 710032, China

Correspondence should be addressed to Boquan Jin; nc.ude.ummf@nij_ummi and Ying Ma; moc.361@02gb_yrrem

Received 12 September 2016; Accepted 12 January 2017; Published 23 March 2017

Academic Editor: Ghislain Opdenakker

Copyright © 2017 Kang Tang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Vaheri, T. Strandin, J. Hepojoki et al., “Uncovering the mysteries of hantavirus infections,” Nature Reviews Microbiology, vol. 11, no. 8, pp. 539–550, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. D. C. Watson, M. Sargianou, A. Papa, P. Chra, I. Starakis, and G. Panos, “Epidemiology of hantavirus infections in humans: a comprehensive, global overview,” Critical Reviews in Microbiology, vol. 40, no. 3, pp. 261–272, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. B. Marcos-Ramiro, D. Garcia-Weber, and J. Millan, “TNF-induced endothelial barrier disruption: beyond actin and rho,” Thrombosis and Haemostasis, vol. 112, no. 6, pp. 1088–1102, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Hepojoki, A. Vaheri, and T. Strandin, “The fundamental role of endothelial cells in hantavirus pathogenesis,” Frontiers in Microbiology, vol. 5, p. 727, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. A. M. Connolly-Andersen, E. Sundberg, C. Ahlm et al., “Increased thrombopoiesis and platelet activation in hantavirus-infected patients,” The Journal of Infectious Diseases, vol. 212, no. 7, pp. 1061–1069, 2015. View at Publisher · View at Google Scholar · View at Scopus
  6. F. Magkos and L. S. Sidossis, “Recent advances in the measurement of adiponectin isoform distribution,” Current Opinion in Clinical Nutrition and Metabolic Care, vol. 10, no. 5, pp. 571–575, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. L. J. Crawford, R. Peake, S. Price, T. C. Morris, and A. E. Irvine, “Adiponectin is produced by lymphocytes and is a negative regulator of granulopoiesis,” Journal of Leukocyte Biology, vol. 88, no. 4, pp. 807–811, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. H. Waki, T. Yamauchi, J. Kamon et al., “Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin,” The Journal of Biological Chemistry, vol. 278, no. 41, pp. 40352–40363, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. Y. Hada, T. Yamauchi, H. Waki et al., “Selective purification and characterization of adiponectin multimer species from human plasma,” Biochemical and Biophysical Research Communications, vol. 356, no. 2, pp. 487–493, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. H. Tilg and A. R. Moschen, “Adipocytokines: mediators linking adipose tissue, inflammation and immunity,” Nature Reviews Immunology, vol. 6, no. 10, pp. 772–783, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. N. Ouchi, J. L. Parker, J. J. Lugus, and K. Walsh, “Adipokines in inflammation and metabolic disease,” Nature Reviews Immunology, vol. 11, no. 2, pp. 85–97, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. J. L. Parker-Duffen, K. Nakamura, M. Silver et al., “T-cadherin is essential for adiponectin-mediated revascularization,” The Journal of Biological Chemistry, vol. 288, no. 34, pp. 24886–24897, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Fasshauer and M. Bluher, “Adipokines in health and disease,” Trends in Pharmacological Sciences, vol. 36, no. 7, pp. 461–470, 2015. View at Publisher · View at Google Scholar · View at Scopus
  14. Y. Yang, W. Hu, S. Jiang et al., “The emerging role of adiponectin in cerebrovascular and neurodegenerative diseases,” Biochimica et Biophysica Acta, vol. 1852, no. 9, pp. 1887–1894, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. T. Jia, J. J. Carrero, B. Lindholm, and P. Stenvinkel, “The complex role of adiponectin in chronic kidney disease,” Biochimie, vol. 94, no. 10, pp. 2150–2156, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. H. Du, X. Bai, J. Lian et al., “Changes in plasma adiponectin concentrations in patients with hemorrhagic fever with renal syndrome: an observational prospective study,” Medicine (Baltimore), vol. 95, no. 6, article e2700, 2016. View at Publisher · View at Google Scholar
  17. S. Esmaili, A. Xu, and J. George, “The multifaceted and controversial immunometabolic actions of adiponectin,” Trends in Endocrinology and Metabolism, vol. 25, no. 9, pp. 444–451, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. Y. Wang, A. Zheng, Y. Yan et al., “Association between HMW adiponectin, HMW-total adiponectin ratio and early-onset coronary artery disease in Chinese population,” Atherosclerosis, vol. 235, no. 2, pp. 392–397, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. F. Omar, J. A. Dave, J. A. King, N. S. Levitt, and T. S. Pillay, “High molecular weight (HMW): total adiponectin ratio is low in hiv-infected women receiving protease inhibitors,” BMC Clinical Pathology, vol. 14, no. 1, p. 46, 2014. View at Publisher · View at Google Scholar
  20. D. C. Sulistyoningrum, D. Gasevic, S. A. Lear, J. Ho, A. Mente, and A. M. Devlin, “Total and high molecular weight adiponectin and ethnic-specific differences in adiposity and insulin resistance: a cross-sectional study,” Cardiovascular Diabetology, vol. 12, p. 170, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. Y. Ma, B. Liu, B. Yuan et al., “Sustained high level of serum VEGF at convalescent stage contributes to the renal recovery after HTNV infection in patients with hemorrhagic fever with renal syndrome,” Clinical & Developmental Immunology, vol. 2012, Article ID 812386, p. 11, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. Z. Liu, Q. Zhao, Q. Han, M. Gao, and N. Zhang, “Serum thrombospondin-1 is altered in patients with hemorrhagic fever with renal syndrome,” Journal of Medical Virology, vol. 80, no. 10, pp. 1799–1803, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. Zhang, C. Zhang, R. Zhuang et al., “IL-33/ST2 correlates with severity of haemorrhagic fever with renal syndrome and regulates the inflammatory response in Hantaan virus-infected endothelial cells,” PLoS Neglected Tropical Diseases, vol. 9, no. 2, article e0003514, 2015. View at Publisher · View at Google Scholar · View at Scopus
  24. C. Kobashi, M. Urakaze, M. Kishida et al., “Adiponectin inhibits endothelial synthesis of interleukin-8,” Circulation Research, vol. 97, no. 12, pp. 1245–1252, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. N. Ouchi, S. Kihara, Y. Arita et al., “Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin,” Circulation, vol. 100, no. 25, pp. 2473–2476, 1999. View at Publisher · View at Google Scholar
  26. N. Maeda, I. Shimomura, K. Kishida et al., “Diet-induced insulin resistance in mice lacking adiponectin/ACRP30,” Nature Medicine, vol. 8, no. 7, pp. 731–737, 2002. View at Publisher · View at Google Scholar · View at Scopus
  27. T. Yokota, K. Oritani, I. Takahashi et al., “Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages,” Blood, vol. 96, no. 5, pp. 1723–1732, 2000. View at Google Scholar
  28. F. Lovren, Y. Pan, A. Quan et al., “Adiponectin primes human monocytes into alternative anti-inflammatory M2 macrophages,” American Journal of Physiology Heart and Circulatory Physiology, vol. 299, no. 3, pp. H656–H663, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. K. Ohashi, J. L. Parker, N. Ouchi et al., “Adiponectin promotes macrophage polarization toward an anti-inflammatory phenotype,” The Journal of Biological Chemistry, vol. 285, no. 9, pp. 6153–6160, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. C. Procaccini, V. De Rosa, M. Galgani et al., “Role of adipokines signaling in the modulation of T cells function,” Frontiers in Immunology, vol. 4, p. 332, 2013. View at Publisher · View at Google Scholar
  31. Y. Takemura, N. Ouchi, R. Shibata et al., “Adiponectin modulates inflammatory reactions via calreticulin receptor-dependent clearance of early apoptotic bodies,” The Journal of Clinical Investigation, vol. 117, no. 2, pp. 375–386, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. H. Ekmekci, O. B. Ekmekci, S. Erdine et al., “Effects of serum homocysteine and adiponectin levels on platelet aggregation in untreated patients with essential hypertension,” Journal of Thrombosis and Thrombolysis, vol. 28, no. 4, pp. 418–424, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. H. Kato, H. Kashiwagi, M. Shiraga et al., “Adiponectin acts as an endogenous antithrombotic factor,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 26, no. 1, pp. 224–230, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. C. Palmer, T. Hampartzoumian, A. Lloyd, and A. Zekry, “A novel role for adiponectin in regulating the immune responses in chronic hepatitis C virus infection,” Hepatology, vol. 48, no. 2, pp. 374–384, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. M. B. Joshi, M. Philippova, D. Ivanov, R. Allenspach, P. Erne, and T. J. Resink, “T-cadherin protects endothelial cells from oxidative stress-induced apoptosis,” The FASEB Journal, vol. 19, no. 12, pp. 1737–1739, 2005. View at Publisher · View at Google Scholar · View at Scopus
  36. A. V. Andreeva, J. Han, M. A. Kutuzov, J. Profirovic, V. A. Tkachuk, and T. A. Voyno-Yasenetskaya, “T-cadherin modulates endothelial barrier function,” Journal of Cellular Physiology, vol. 223, no. 1, pp. 94–102, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. C. Hug, J. Wang, N. S. Ahmad, J. S. Bogan, T. S. Tsao, and H. F. Lodish, “T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 28, pp. 10308–10313, 2004. View at Publisher · View at Google Scholar · View at Scopus
  38. H. Kobayashi, N. Ouchi, S. Kihara et al., “Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin,” Circulation Research, vol. 94, no. 4, pp. e27–e31, 2004. View at Publisher · View at Google Scholar
  39. L. Shen, J. Miao, F. Yuan et al., “Overexpression of adiponectin promotes focal angiogenesis in the mouse brain following middle cerebral artery occlusion,” Gene Therapy, vol. 20, no. 1, pp. 93–101, 2013. View at Publisher · View at Google Scholar · View at Scopus
  40. J. Yi, Z. Xu, R. Zhuang et al., “Hantaan virus RNA load in patients having hemorrhagic fever with renal syndrome: correlation with disease severity,” The Journal of Infectious Diseases, vol. 207, no. 9, pp. 1457–1461, 2013. View at Publisher · View at Google Scholar · View at Scopus
  41. K. Ohashi, N. Ouchi, K. Sato et al., “Adiponectin promotes revascularization of ischemic muscle through a cyclooxygenase 2-dependent mechanism,” Molecular and Cellular Biology, vol. 29, no. 13, pp. 3487–3499, 2009. View at Publisher · View at Google Scholar · View at Scopus
  42. J. M. Rutkowski, N. Halberg, Q. A. Wang, W. L. Holland, J. Y. Xia, and P. E. Scherer, “Differential transendothelial transport of adiponectin complexes,” Cardiovascular Diabetology, vol. 13, p. 47, 2014. View at Publisher · View at Google Scholar · View at Scopus
  43. N. Halberg, T. D. Schraw, Z. V. Wang et al., “Systemic fate of the adipocyte-derived factor adiponectin,” Diabetes, vol. 58, no. 9, pp. 1961–1970, 2009. View at Publisher · View at Google Scholar · View at Scopus